News Summary

Vancouver-based startup Variational, founded in 2019 by former D-Wave employees Handol Kim, Jason Rolfe, and Ali Saberali, has announced a significant partnership with pharmaceutical giant Merck. This nine-figure deal will involve Variational utilizing its AI platform to generate molecular candidates for therapeutic targets, marking a notable achievement in the field of AI-driven drug discovery.